Home  >  TopNews
Corporate + Font Resize -

Telangana govt's Industrial Policy TS-iPass makes pharma cos easy to invest in Telangana

A Raju, Hyderabad
Wednesday, January 10, 2018, 08:00 Hrs  [IST]

The Telangana government's new industrial policy TS-iPass, launched two years ago, is getting kudos from the industry as majority of pharma companies have termed the new and innovative policy as one of the best industrial policies adopted by any state in the country.

Recently, DelExcel Pharam Company, which had come forward to set up its manufacturing base in Telangana, termed the state’s industrial policy as new and innovative. Because of this new industrial policy the Telangana state has attracted many national and international companies to its fold for setting up manufacturing bases here in Hyderabad.
 
“We are setting up a Rs. 50 crore greenfield manufacturing facilities at Kucharam Village near Manoharabad in Medak. We have already finished the construction of a plant and approached the drug control administration department for drug licensing.

The TS-iPass is indeed a simple and transparent process from where we get all clearance within 15 days for setting up a plant, whereas earlier it used to take months and years. To my surprise, the entire process is online and I received the license in less than a week’s time,” says Raghupati Kandarapu, co founder and chief executive officer of DelExcel Pharma.

Not just pharma, the state’s TS-iPass industrial policy has also provided a platform for various companies to clearly see the comparative advantage in setting up their bases in Telangana state. As per recent survey, the Telangana State has topped the national ranking in terms of ease of doing business (EoDB).

Bulk Drug Manufacturing Association former president Jayanth Tagore also hailed the initiatives taken up by the Telangana government particularly for strengthening the pharmaceutical base in the state. “The state government of Telangana is in the forefront to strengthen its pharmaceutical sector. The pro-active initiatives of the state government and the innovative industrial policy have attracted the attention of not only domestic pharma sector companies but also some of the international companies,” observed Tagore.

Attracted by the new industrial policy of the state, DelExcel has already finished its Rs. 50 crore greenfield manufacturing facility and it is in the final stage of getting ready for production soon. Many pharma players are interested to set up their manufacturing bases in and around Hyderabad because the city is well connected to international airport and can also have access to many ancillary units and research institutions.

 

*POST YOUR COMMENT
Comments
* Name :     
* Email :    
  Website :  
   
     
 
ipc_2018
cphi-india_Banner-150x60
 
 
 
 
Copyright © 2016 Saffron Media Pvt. Ltd |